314 related articles for article (PubMed ID: 16178132)
1. Efficacy of a high bioavailable cetylpyridinium chloride mouthrinse over a 24-hour period: a plaque imaging study.
Kozak KM; Gibb R; Dunavent J; White DJ
Am J Dent; 2005 Jul; 18 Spec No():18A-23A. PubMed ID: 16178132
[TBL] [Abstract][Full Text] [Related]
2. The effect of toothbrushing regimens on the plaque inhibitory properties of an experimental cetylpyridinium chloride mouthrinse.
Witt J; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
J Clin Periodontol; 2006 Oct; 33(10):737-42. PubMed ID: 16899026
[TBL] [Abstract][Full Text] [Related]
3. In vivo antiplaque efficacy of combined antimicrobial dentifrice and rinse hygiene regimens.
White DJ; Barker ML; Klukowska M
Am J Dent; 2008 Jun; 21(3):189-96. PubMed ID: 18686773
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in preventing dental plaque.
Lotufo R; Calil CM; Feng HS; Sekiguchi RT; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):50-4. PubMed ID: 19591337
[TBL] [Abstract][Full Text] [Related]
5. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in reducing dental plaque.
Hernandez-Cott PL; Elias Boneta A; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):39-44. PubMed ID: 19591335
[TBL] [Abstract][Full Text] [Related]
6. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis.
Silva MF; dos Santos NB; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):55-61. PubMed ID: 19591338
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and antiplaque effects of a novel, alcohol-free oral rinse with cetylpyridinium chloride.
Witt J; Ramji N; Gibb R; Dunavent J; Flood J; Barnes J
J Contemp Dent Pract; 2005 Feb; 6(1):1-9. PubMed ID: 15719071
[TBL] [Abstract][Full Text] [Related]
8. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque.
Mankodi S; Bauroth K; Witt JJ; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
Am J Dent; 2005 Jul; 18 Spec No():9A-14A. PubMed ID: 16178130
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind clinical study to assess the antimicrobial effects of a cetylpyridinium chloride mouth rinse on dental plaque bacteria.
Hu D; Li X; Sreenivasan PK; DeVizio W
Clin Ther; 2009 Nov; 31(11):2540-8. PubMed ID: 20109998
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antiplaque efficacy of two cetylpyridinium chloride-containing mouthwashes.
Barnes VM; Arvanitidou E; Szewczyk G; Richter R; DeVizio W; Cronin M; Michelle S
J Clin Dent; 2011; 22(6):200-3. PubMed ID: 22403976
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a mouthrinse containing 0.05% cetylpyridinium chloride for the control of plaque and gingivitis: a 6-month clinical study in adults.
Allen DR; Davies R; Bradshaw B; Ellwood R; Simone AJ; Robinson R; Mukerjee C; Petrone ME; Chaknis P; Volpe AR; Proskin HM
Compend Contin Educ Dent; 1998; 19(2 Suppl):20-6. PubMed ID: 10371878
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial to compare plaque inhibition of a sodium fluoride/potassium nitrate dentifrice versus a stabilized stannous fluoride/sodium hexametaphosphate dentifrice.
Bellamy PG; Khera N; Day TN; Barker ML; Mussett AJ
J Contemp Dent Pract; 2009 Mar; 10(2):1-9. PubMed ID: 19279966
[TBL] [Abstract][Full Text] [Related]
13. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria.
He S; Wei Y; Fan X; Hu D; Sreenivasan PK
J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975
[TBL] [Abstract][Full Text] [Related]
14. Superiority of an essential oil mouthrinse when compared with a 0.05% cetylpyridinium chloride containing mouthrinse: a six-month study.
Sharma NC; Araujo MW; Wu MM; Qaqish J; Charles CH
Int Dent J; 2010 Jun; 60(3):175-80. PubMed ID: 20684443
[TBL] [Abstract][Full Text] [Related]
15. Practice implications with an alcohol-free, 0.07% cetylpyridinium chloride mouthrinse.
Blenman TV; Morrison KL; Tsau GJ; Medina AL; Gerlach RW
Am J Dent; 2005 Jul; 18 Spec No():29A-34A. PubMed ID: 16178134
[TBL] [Abstract][Full Text] [Related]
16. Comparative clinical trial of two antigingivitis mouthrinses.
Witt JJ; Walters P; Bsoul S; Gibb R; Dunavent J; Putt M
Am J Dent; 2005 Jul; 18 Spec No():15A-17A. PubMed ID: 16178131
[TBL] [Abstract][Full Text] [Related]
17. Effect of a stannous fluoride dentifrice on plaque formation and removal: a digital plaque imaging study.
White DJ
J Clin Dent; 2007; 18(1):21-4. PubMed ID: 17410952
[TBL] [Abstract][Full Text] [Related]
18. A 24-hour dental plaque prevention study with a stannous fluoride dentifrice containing hexametaphosphate.
White DJ; Kozak KM; Gibb R; Dunavent J; Klukowska M; Sagel PA
J Contemp Dent Pract; 2006 Jul; 7(3):1-11. PubMed ID: 16820802
[TBL] [Abstract][Full Text] [Related]
19. An alcohol-free therapeutic mouthrinse with cetylpyridinium chloride (CPC)--the latest advance in preventive care: Crest Pro-Health Rinse.
White DJ
Am J Dent; 2005 Jul; 18 Spec No():3A-8A. PubMed ID: 16178129
[No Abstract] [Full Text] [Related]
20. Influence of a SLS-containing dentifrice on the anti-plaque efficacy of a chlorhexidine mouthrinse.
Van Strydonck DA; Scalé S; Timmerman MF; van der Velden U; van der Weijden GA
J Clin Periodontol; 2004 Mar; 31(3):219-22. PubMed ID: 15016027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
